Diagnostic sales also have been strong for companies including Abbott Laboratories, which had $7.7 billion in Covid-19 test sales last year. Last week, Moderna reported $17.7 billion in sales of its Covid-19 vaccine Spikevax for 2021, and predicted it would generate at least $19 billion in Covid vaccine sales this year. The company is developing a combination flu and Covid vaccine, and is testing experimental vaccines against other viruses in late-stage studies. The expected Covid-19 sales could push Pfizer's total company sales over $100 billion for the first time in its history. AstraZeneca's Covid-19 vaccine was its second biggest seller in 2021, at $4.1 billion in revenue.

Source: Bangkok Post February 28, 2022 06:14 UTC